HTG Molecular Diagnostics Announces $7.5 Million Private Placement

TUCSON, Ariz. , March 18, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has entered into a definitive securities purchase agreement to sell securities in a private